We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 1,227 results
  1. Neuroprotection in Neurodegenerative Disorders

    Although the concept of neuroprotection was originally applied to acute neurological conditions, it has been extended to chronic diseases of the...
    Protocol 2019
  2. Side Effects of Chloroquine and Hydroxychloroquine on Skeletal Muscle: a Narrative Review

    Purpose of Review

    Concerning adverse neuromuscular effects, there are quite a few reports about the incidence and prevalence of chloroquine (CQ) and...

    Alzira Alves de Siqueira Carvalho in Current Pharmacology Reports
    Article 31 October 2020
  3. Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis

    The juvenile form of neuronal ceroid Lipofuscinosis (JNCL) is the most common form within this group of rare lysosomal storage disorders, causing...

    Gemma Gomez-Giro, Jonathan Arias-Fuenzalida, ... Jens C. Schwamborn in Acta Neuropathologica Communications
    Article Open access 30 December 2019
  4. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome

    The gut microbiota shapes the response to immune checkpoint inhibitors (ICIs) in cancer, however dietary and geographic influences have not been...

    Rebecca C. Simpson, Erin R. Shanahan, ... Georgina V. Long in Nature Medicine
    Article 22 September 2022
  5. Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology

    This review summarizes the pathogenic mechanisms that underpin the monogenic epilepsies and discusses the potential of novel precision therapeutics...

    Gemma L. Carvill, Tyler Matheny, ... Scott Demarest in Neurotherapeutics
    Article 01 July 2021
  6. Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future

    Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders, which lack an enzyme corresponding to the specific type of MPS. Enzyme...

    Hui Hsuan Chen, Kazuki Sawamoto, ... Shunji Tomatsu in Journal of Human Genetics
    Article 27 August 2019
  7. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has dramatically expedited global vaccine development efforts 1 3 , most...

    Jennifer A. Juno, Hyon-Xhi Tan, ... Adam K. Wheatley in Nature Medicine
    Article 13 July 2020
  8. Preconception expanded carrier screening: a focus group study with relatives of mucopolysaccharidosis type III patients and the general population

    Preconception expanded carrier screening (ECS) enables prospective parents to assess their risk of having a child with an autosomal recessive...

    Thirsa Conijn, Ivy van Dijke, ... Lidewij Henneman in Journal of Community Genetics
    Article Open access 22 March 2021
  9. Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation

    Prion diseases are caused by the propagation of PrP Sc , the pathological conformation of the PrP C prion protein. The molecular mechanisms underlying...

    Aline Bamia, Maha Sinane, ... Cécile Voisset in Neurotherapeutics
    Article 02 February 2021
  10. Further Characterization of the Predominant Inner Retinal Degeneration of Aging Cln3 Δex7/8 Knock-In Mice

    Neuronal ceroid lipofuscinosis (NCL) is the most common group of neurogenetic storage diseases typically beginning in childhood. The juvenile form...
    Cornelia Volz, Myriam Mirza, ... Herbert Jägle in Retinal Degenerative Diseases
    Conference paper 2018
  11. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead

    Most rare diseases still lack approved treatments despite major advances in research providing the tools to understand their molecular basis, as well...

    Erik Tambuyzer, Benjamin Vandendriessche, ... Marco Prunotto in Nature Reviews Drug Discovery
    Article 13 December 2019
  12. Syndromic Disorders

    This chapter summarizes the application of visual electrophysiology in syndromic disorders involving the retina. The characteristics of...
    Alfonso Senatore, Wajiha Jurdi Kheir, ... Alessandro Iannaccone in Handbook of Clinical Electrophysiology of Vision
    Chapter 2019
  13. Peste des Petits Ruminants

    Peste des petits ruminants (PPR) is a contagious viral disease of domestic and wild small ruminants. Clinically, it is characterized by fever,...
    Adama Diallo, Arnaud Bataille, ... Geneviève Libeau in Transboundary Animal Diseases in Sahelian Africa and Connected Regions
    Chapter 2019
  14. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus Disease 2019 (COVID-19), has caused a global...

    Katie J. Ewer, Jordan R. Barrett, ... Elizabeth Stafford in Nature Medicine
    Article 17 December 2020
  15. Nutrition and Hydration in Palliative Care and Their Diverse Meanings

    Essential for life, food and fluids are regarded as basic care, professionally, ethically, and legally. This chapter seeks to contextualize and...
    Jean B. Clark, Lesley S. Batten in Textbook of Palliative Care
    Reference work entry 2019
  16. Strategies for delivering therapeutics across the blood–brain barrier

    Achieving sufficient delivery across the blood–brain barrier is a key challenge in the development of drugs to treat central nervous system (CNS)...

    Georg C. Terstappen, Axel H. Meyer, ... Wandong Zhang in Nature Reviews Drug Discovery
    Article 01 March 2021
  17. Gene Therapy for Inborn Errors of Metabolism: Batten Disease

    The development of a gene therapy for inborn errors of metabolism is a multifaceted challenge that rides on organizational, financial, and scientific...
    Dolan Sondhi, Ronald G. Crystal, Stephen M. Kaminsky in Translational Neuroscience
    Chapter 2016
  18. Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences

    Neuropharmacokinetics considers cerebral drug distribution as a critical process for central nervous system drug action as well as for drug...
    Fanchon Bourasset, Sylvain Auvity, ... Jean-Michel Scherrmann in Physiology, Pharmacology and Pathology of the Blood-Brain Barrier
    Chapter 2020
  19. Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration

    Inherited retinal diseases (IRDs) comprise a clinically and genetically heterogeneous group of disorders that can ultimately result in photoreceptor...

    Paula I. Fuller-Carter, Hamed Basiri, ... Livia S. Carvalho in BioDrugs
    Article 02 November 2020
  20. Understanding the Pathogenicity of Noncoding RNA Expansion-Associated Neurodegenerative Disorders

    Recent decades of cutting-edge research have unraveled abnormal nucleotide repeat expansions that manifest themselves in the form of neuronal or...
    Rituparna Das, Mouli Chakraborty, ... Mousumi Mutsuddi in Insights into Human Neurodegeneration: Lessons Learnt from Drosophila
    Chapter 2019
Did you find what you were looking for? Share feedback.